通过MST1-静止增强功能性胰岛素生成细胞与胚胎干细胞的分化
Hui Song1,2,3, Jiarui Li1,2, Haohao Yang1,2
1Basic Medical School of Ningxia Medical University, Yinchuan, 750004, China.
Diabetology & metabolic syndrome
|March 20, 2025
概括
在胚胎干细胞 (ESC) 中抑制哺乳动物三蛋白激酶 (MST1) 增强了胰岛素生成细胞 (IPC) 的分化和功能. 这种方法改善了糖尿病老鼠的血糖控制,为糖尿病细胞治疗提供了一种新的策略.
科学领域:
- 干细胞生物学 干细胞生物学
- 内分泌学 在内分泌学.
- 细胞疗法是一种细胞疗法.
背景情况:
- 岛屿β细胞移植是一种关键的糖尿病治疗方法.
- 转录因子PDX1对于β细胞功能至关重要.
- 哺乳动物氨酸蛋白激酶 (MST1) 调节PDX1,但其在ESC分化中的作用尚不清楚.
研究的目的:
- 研究MST1沉默对胚胎干细胞 (ESC) 分化成产生胰岛素的细胞 (IPC) 的影响.
主要方法:
- 这些ESC被MST1-沉默的lentiviral载体 (shMST1) 感染.
- 在体外分析IPC时使用qRT-PCR,免疫光,流细胞计,西斑和ELISA.
- IPC被移植到1型糖尿病 (T1DM) 的老鼠体内,并对血糖和胰岛素水平进行监测.
主要成果:
- 在体外,MST1沉默改善了IPC胰岛素分泌和葡萄糖反应.
- 移植的IPC使T1DM大鼠的血糖正常化和胰岛素水平增加.
- 抑制MST1增强了体外IPC功能和体内治疗疗效.
结论:
- 准MST1提供了一种新的方法,可以从ESC中生成成熟的IPC.
- 这一策略有可能促进糖尿病细胞替代疗法的发展.
- 开发具有强大的胰岛素分泌的IPC对于有效治疗糖尿病至关重要.
更多相关视频
08:29Endothelial Cell Co-culture Mediates Maturation of Human Embryonic Stem Cell to Pancreatic Insulin Producing Cells in a Directed Differentiation Approach
Published on: March 27, 2012
16.2K
09:23Efficient Differentiation of Pluripotent Stem Cells to NKX6-1+ Pancreatic Progenitors
Published on: March 7, 2017
7.9K
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K
